Establishment of heterozygous LMOD2 knockout human embryonic stem cell line (ZZUNEUi022-A-1) using CRISPR/Cas9 system
Summary
Dilated Cardiomyopathy (DCM), a prevalent form of cardiomyopathy, is characterized by ventricular dilation and systolic dysfunction. Its etiology is intricate, encompassing multiple genetic and environmental elements. The LMOD2 (Leiomodin 2) gene has been demonstrated to be closely associated with the pathogenesis of DCM. In this study, a pure cell line was generated by knocking out the LMOD2 gene, and a DCM cell model was established through induced differentiation, thus providing a powerful experimental approach for further understanding the pathogenesis of DCM. It also provides a potential research orientation for the early diagnosis and individualized treatment of DCM. Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.
Authors | Zhang C, Li J, Sai Y, Su H, Jiang Y, Zhang L, Jian L, Zhang H, Guo G, Li E, Li X, Sun L |
---|---|
Journal | Stem cell research |
Publication Date | 2024 Dec;81:103586 |
PubMed | 39437564 |
DOI | 10.1016/j.scr.2024.103586 |